AKT1 and familial pancreatic carcinoma: Literature suggests that AKT (serine/threonine kinase), is responsible for providing resistance to chemotherapy as it is found to be hyperactive in pancreatic cancer and reports have shown that inhibition of AKT signaling increases the chemosensitisation of drugs [49].